About Amyris
Amyris Biotechnologies creates renewable products that focus on fuels and chemicals that provide no-compromise sustainable alternatives to a broad range of petroleum-sourced products. It uses an industrial synthetic biology platform that applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. Its technology creates products that support biopharmaceutical drug discovery and production, from cosmetic emollients and fragrances to fuels, solvents, lubricants, and nutraceuticals.
Open positions (3)
Company details
Funding
Total raised
$487M
Last stage
Public
Investors
Founders
Jay D. Keasling
Professor of chemical engineering and bioengineering at UC Berkeley and associate laboratory director for biosciences at Lawrence Berkeley National Laboratory. A leading authority in synthetic biology and metabolic engineering.
Jack D. Newman
UC Berkeley postdoc in molecular and cellular biology; co-founded Amyris with Keasling and later founded Zagaya to continue fighting malaria.
Neil Renninger
Holds a UC Berkeley Ph.D. (2001) in chemical engineering. Later went on to found Ripple Foods and Ample Carbon.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.